Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Soroka University Medical Center |
---|---|
Information provided by: | Soroka University Medical Center |
ClinicalTrials.gov Identifier: | NCT00479102 |
Healthy babies(age 8-18 months) following a routine blood count, with no anemia or iron deficiency, will be randomly placed in two groups. Group 1 will receive a 3 months preventive dose of an iron preparation (Ferripel 3 iron polysaccharide complex). Group 2 will be followed up as a control group.
Following a nutritional questionnair, parents of all babies will receive instruction regarding appropriate nutrition in the 2nd year of life. A follow-up blood count will be taken from all participating babies 3 months after recruitment. The study aims to evaluate effectiveness of iron supplementation in the 2nd year of life. The hypothesis is that babies who receive iron supplementation in the 2nd year of life are less likely to develop iron deficiency or anemia.
Condition | Intervention | Phase |
---|---|---|
Iron Deficiency Anemia |
Drug: Ferripel-3 - iron polysaccharide complex for prevention |
Phase IV |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Open Label, Historical Control, Single Group Assignment, Efficacy Study |
Official Title: | Effectiveness of Iron Supplementation in the Second Year of Life for Prevention of Iron Deficiency |
Ages Eligible for Study: | 8 Months to 18 Months |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Hanna Shalev, MD | 972-52-8504058 | hannash@clalit.org.il |
Israel | |
Clalit Health Services Child Health Center | |
Rahat, Israel |
Principal Investigator: | Hanna Shalev, MD | Clalit Health Services |
Study ID Numbers: | sor448707ctil |
Study First Received: | May 24, 2007 |
Last Updated: | May 24, 2007 |
ClinicalTrials.gov Identifier: | NCT00479102 History of Changes |
Health Authority: | Israel: Ministry of Health |
Iron supplementation Babies Prevention |
Metabolic Diseases Hematologic Diseases Anemia Trace Elements Micronutrients |
Iron Metabolism Disorders Iron Metabolic Disorder Anemia, Iron-Deficiency |
Metabolic Diseases Hematologic Diseases Growth Substances Physiological Effects of Drugs Anemia Anemia, Hypochromic |
Trace Elements Micronutrients Iron Metabolism Disorders Iron Pharmacologic Actions Anemia, Iron-Deficiency |